857328P-1MG Display Image

18:1 CYCLIC LPA

Code: 857328P-1MG D2-231

Application

18:1 Cyclic LPA has been used for the preparation of liposomes. It has also been used for the extraction recovery of cyclic phosphatidic acid (cPA) at different p...


read more

Your Price
£213.00 1MG

Application

18:1 Cyclic LPA has been used for the preparation of liposomes. It has also been used for the extraction recovery of cyclic phosphatidic acid (cPA) at different pH conditions using Bligh−Dyer method.

General description

Cyclic phosphatidic acid (cPA) is a naturally occurring analog of the growth factor-like phospholipid mediator, lysophosphatidic acid (LPA). The sn-2 hydroxy group of CPA forms a 5-membered ring with the sn-3 phosphate. cPA affects numerous cellular functions, including anti-mitogenic regulation of the cell cycle, induction of stress fiber formation, inhibition of tumor cell invasion and metastasis, and regulation of differentiation and survival of neuronal cells. Interestingly, many of these cellular responses caused by cPA oppose those of LPA despite the activation of apparently overlapping receptor populations.

Packaging

5 mL PTFE Vial with Screw Cap (857328P-1mg)

assay>99% (TLC)
formpowder
manufacturer/tradenameAvanti Polar Lipids 857328P
packagingpkg of 1 × 1 mg (857328P-1mg)
shipped indry ice
SMILES stringO=C(CCCCCCC/C=CCCCCCCCC)OC[C@@H]1COP(O1)([O-])=O.[NH4+]
storage temp.−20°C
Cas Number799268-72-7
This product has met the following criteria: